Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects

NCT01721980 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GLPG0974
DRUG: Placebo

Sponsor

Lakefront Biotherapeutics NV